[Pubmed] Comparison of outcomes in patients with and without neurologic diseases undergoing holmium laser enucleation of
Posté : 08 avr. 2024 12:00
Can Urol Assoc J. 2024 Apr 2. doi: 10.5489/cuaj.8683. Online ahead of print.
ABSTRACT
INTRODUCTION: We aimed to compare holmium laser enucleation of the prostate (HoLEP) outcomes in patients with and without neurologic diseases (ND).
METHODS: A prospectively maintained database of patients undergoing HoLEP from January 2021 to April 2022 was reviewed. The following NDs were included: diabetes-related neuropathy/neurogenic bladder, Parkinson's disease, dementia, cerebrovascular accident, multiple sclerosis, traumatic brain injury, transient ischemic attack, brain/spinal tumors, myasthenia gravis, spinal cord injury, and other. Statistical analysis was performed using t-tests, Chi-squared, and binomial tests (p
Source: https://pubmed.ncbi.nlm.nih.gov/3858797 ... t9+e462414